Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTern Regulatory News (TERN)

Share Price Information for Tern (TERN)

Share Price is delayed by 15 minutes
Get Live Data
1.175    0.075 (6.82%)
Bid:
1.10
Ask:
1.25
Spread: 0.15 (13.636%)
Market Cap: £10.05m
TERN Live PriceLast checked at - London Stock Exchange

Intraday Tern Share Chart

Directorate Change

2 Dec 2010 09:50

RNS Number : 2496X
Chalkwell Investments PLC
02 December 2010
 



Chalkwell Investments plc.

("Chalkwell" or the "Company")

Appointment of Directors

 

Dated: 2 December 2010

Chalkwell, the AIM-quoted investment company, with a focus on the resource sector, is pleased to announce today the appointments of Mr. Bruce Evers as Executive Chairman and Mr. Reinhold Heus as Non-Executive Director with immediate effect.

Mr. Evers has a BA (Hons) degree in Modern Languages, Politics, History from Trinity College, University of Toronto. He started his career in 1983 as an Oil and Gas Analyst at Panmure Gordon, before moving to Laurence Prust, Schroder Securities, Yamaichi International (Europe) Limited and Investec, where he worked for 12 years. Subsequently, Mr. Evers worked as a Corporate Broker at Evolution Securities, Fairfax and BDR Securities.

Mr. Heus graduated with a BSc degree in Economics from Vrije Universiteit, Amsterdam. He started his career in 1982 with Royal Dutch Shell in Rotterdam as an Oil Trader before being promoted to Assistant to Head of Group Planning. Mr. Heus transferred to Royal Dutch Shell in London as a Business Development Manager in 1986 and was later an Acquisitions Manager. Mr. Heus was Director of International Mergers & Acquisitions for the Energy sector at Daiwa Securities from 1989 before becoming Head Emerging Markets Division. In 1995, Mr. Heus was the Head of Global Corporate Finance Division of ANZ Investment Bank before moving to 3i Group plc as a Senior Advisor to the Board. Since 2003, Mr. Heus has been a Director with Faircourt Capital Group Ltd, a private consulting firm focused on the global Energy & Resources sectors.

The following are details of all current and former directorships in the previous five years held by Mr. Bruce Evers and Mr. Reinhold Heus:

Full Name: Bruce George Alexander Evers

 Current Directorships

Former Directorships

30 Elsham Road London W14 Limited

BDR Securities Limited

-

Full Name: Reinhold Heus

 

 

Current Directorships

Former Directorships

Faircourt Capital Group Ltd

Faircourt Capital Limited

Faircourt Energy Limited

Faircourt Resources Limited

Faircourt Energy Group Limited

World Light Web Limited

 

Faircourt International Ltd

News Air Lease Limited

Transvision Resources Plc

Faircourt (Benelux) Ltd

Faircourt (Nordic) Ltd

Faircourt Group Limited

United African Airways Limited

Faircourt (Asia) Ltd

 

There are no further details to be disclosed under Rule 17 schedule 2 paragraph (f) of the AIM Rules in relation to Mr. Bruce Evers and Mr. Reinhold Heus.

 

ENDS

 

For further information please contact:

 

Chalkwell Investments plc

Nigel Weller, Director +44 (0)7769 906 906

 

Religare Capital Markets (Nomad)

Nick Harriss/Emily Staples +44 (0)20 7444 0800

 

Religare Capital Markets (Broker)

Daniel Briggs +44 (0)20 7444 0500

 

Bishopgate Communications

Michael Kinirons +44 (0)20 7562 3350

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGCBDDISGBGGD
Date   Source Headline
31st Dec 20241:30 pmRNSTotal Voting Rights
23rd Dec 202411:39 amRNSDevice Authority update
16th Dec 20247:01 amRNS-ROnline Investor Presentation and Q&A Session
16th Dec 20247:00 amRNSPlacing to raise £400,000
1st Nov 20247:00 amRNSDirector/PDMR Shareholding
29th Oct 20247:00 amRNSBoard Changes
25th Oct 20248:27 amRNSFurther re. Wyld Networks Rights Issue
15th Oct 20247:00 amRNSPlacing to raise £625,000
30th Sep 20245:04 pmRNSTotal Voting Rights
30th Sep 20247:00 amRNSDevice Authority Update
23rd Sep 202411:13 amRNSReplacement: Results of Open Offer
23rd Sep 202411:10 amRNSResult of General Meeting
23rd Sep 20247:00 amRNSResults of Open Offer
5th Sep 20247:00 amRNSOpen Offer and Notice of General Meeting
5th Sep 20247:00 amRNSInterim results for the six months to 30 June 2024
2nd Sep 202410:16 amRNSStatement re Wyld Networks Rights Issue
9th Aug 20247:00 amRNSPartial sale of Device Authority holding
27th Jun 202412:00 pmRNSResult of AGM
31st May 20245:00 pmRNSTotal Voting Rights
30th May 20247:00 amRNSResults for the year ended 31 December 2023
15th May 20247:00 amRNSExercise of Warrants
3rd May 20247:45 amRNSFurther re. Wyld Networks Warrant Exercise Process
30th Apr 20245:00 pmRNSTotal Voting Rights
25th Apr 20247:00 amRNSExercise of warrants held in Wyld Networks
12th Apr 20247:00 amRNSPlacing to raise £420,000
9th Apr 20247:00 amRNSTalking Medicines record revenue bookings in Q1 24
21st Mar 20247:00 amRNSOnline Investor Presentation and Q&A Session
5th Mar 20247:00 amRNSKonektio Administration
7th Feb 20247:00 amRNSDevice Authority Fund Raise
1st Feb 20247:00 amRNSTalking Medicines Fundraise
31st Jan 20245:32 pmRNSTotal Voting Rights
24th Jan 20247:00 amRNSPlacing to raise £400,000
15th Jan 20243:22 pmRNSHolding(s) in Company
28th Dec 20237:00 amRNSCompletion of Tranche One of the DA Fund raise
27th Dec 20237:00 amRNSDevice Authority Fund raise
29th Nov 20237:00 amRNSKonektio update
24th Nov 20237:00 amRNSInvestor Webinar Recording
21st Nov 20237:00 amRNSCompany and Portfolio Update
15th Nov 20237:00 amRNSOnline Investor Presentation and Q&A Session
8th Nov 20237:00 amRNSKonektio update
26th Sep 202312:19 pmRNSResult of GM
31st Aug 20237:00 amRNSNotice of General Meeting
16th Aug 20237:00 amRNSInterim results for the six months to 30 June 2023
10th Aug 20237:00 amRNSBoard and Management Restructuring
4th Aug 20231:33 pmRNSStatement re Share Price Movement
4th Jul 20237:00 amRNSDevice Authority convertible loan note extension
30th Jun 20235:00 pmRNSTotal Voting Rights
29th Jun 202310:09 amRNSResult of AGM and Directorate Change
28th Jun 20237:00 amRNSDevice Authority - Winner of Microsoft Award
12th Jun 202311:35 amRNSFunding facility

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.